RecruitingNCT06742437

Efficacy and Safety of a New Sperm Capacitation Method

Efficacy and Safety of a New Sperm Capacitation Method: a Prospective in Vitro Study on Semen Samples

Sponsor

Fecundis Lab SL

Enrollment

300 participants

Start Date

Jan 14, 2025

Study Type

OBSERVATIONAL

Conditions

oligozoospermia teratozoospermia asthenozoospermia Male infertility Reproductive Issues

Summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.

Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called HyperSperm and a medical device called Standard sperm preparation for people with male infertility, reproductive issues, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include men aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.